Medical Developments International Limited (ASX:MVP)

Australia · Delayed Price · Currency is AUD

0.4350

+0.0050 (1.16%)

Mar 4, 2026, 2:16 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Pain Management	26.19M	21.30M	20.45M	13.27M	19.54M
Pain Management Growth	22.98%	4.15%	54.12%	-32.08%	48.70%
Respiratory	12.87M	11.85M	11.72M	8.22M	5.36M
Respiratory Growth	8.55%	1.13%	42.58%	53.47%	-40.79%
Other	-	-	169.00K	455.00K	-
Other Growth	-	-	-62.86%	-	-
Veterinary	-	-	-	-	380.00K
Veterinary Growth	-	-	-	-	8.26%
Total	39.06M	33.15M	32.34M	21.94M	25.27M
Total Growth	17.82%	2.51%	47.37%	-13.17%	12.15%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Australia	18.83M	15.36M	13.62M	10.82M	8.24M
Australia Growth	22.55%	12.77%	25.90%	31.29%	-31.93%
Europe	9.31M	7.42M	7.99M	5.63M	11.64M
Europe Growth	25.58%	-7.21%	42.02%	-51.65%	-
United States	7.28M	6.28M	4.59M	2.90M	1.65M
United States Growth	15.91%	36.78%	58.06%	76.53%	-
Rest of The World	3.64M	4.09M	6.13M	2.59M	3.68M
Rest of The World Growth	-11.08%	-33.28%	136.68%	-29.56%	-
Unallocated	-	-	-	-	68.00K
Total	39.06M	33.15M	32.34M	21.94M	25.27M
Total Growth	17.82%	2.51%	47.37%	-13.17%	6.90%

Source: S&P Global Market Intelligence.